Another study conducted in 437 Chinese NSCLC patients show XPC rs2228001 is associated with an increased risk of grade 3-4 leukocytopenia in dominant model (OR = 2.217; 95% CI: 1.054–4.665; p = 0.036) (Zheng et al., 2017). The gene discussed is XPC; the disease is non-small cell lung carcinoma.